Biotech · Private company · San Diego, CA, US

Epigen Biosciences, Inc.

Track this companyFree. Adds Epigen Biosciences, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards3

Novel Methods for Nicotinic Receptor Modulation in the Treatment of Post-Operative PainFiscal year 2025 · $350KNIH RePORTER 1R41GM165098-01A1 · fetched Nov 12, 2026
Novel Product Formulation toModulate Alpha7 Nicotinic Receptors for Therapy in Stroke RecoveryFiscal year 2024 · $550.9KNIH RePORTER 1R43NS135837-01A1 · fetched Nov 12, 2026
Candidate selection of a LPAR1 antagonist for therapeutic application in NASHFiscal year 2024 · $1MNIH RePORTER 5R44DK129071-03 · fetched Nov 12, 2026